New diet drugs like Ozempic, Wegovy, and Semaglutide aid weight loss, but experts stress exercise's broader health benefits and the importance of combining them with medication.

The Massachusetts State Auditor's audit found that CHIA failed to monitor hospitals' financial stability properly, risking essential services and not enforcing due fines.

Bird flu detected in a backyard flock in Vermont; 24 birds euthanized, and health officials monitor potential human contact while emphasizing biosecurity to prevent spread.

Boston has launched a strategy to combat the opioid crisis by distributing naloxone and harm reduction supplies via vending machines and kiosks throughout the city.

Methuen schools are implementing strict food rules and enhanced maintenance to combat a mice infestation, with the superintendent committing to improve conditions and work with pest control experts.

Harvard researchers discovered how gliomas connect with brain cells, revealing that targeting neuron-glioma interaction could offer new treatment strategies.

Boston launches "Heads Up Boston," a campaign to destigmatize youth mental health, initiated by Mayor Michelle Wu and the BPHC, emphasizing peer support and inclusion.

A Harvard study suggests replacing meat with plant proteins can reduce heart disease and coronary heart disease risks, emphasizing benefits from legumes and nuts.

MIT engineers have developed an adjustable gastric balloon for weight loss that can be inflated or deflated to help avoid the plateauing effect of traditional gastric balloons.

Over half the adult U.S. population may become eligible for a new anti-obesity drug, semaglutide, with implications for those with diabetes and heart issues.

Recent research links prolonged sitting to an increased risk of heart disease, even with regular exercise, suggesting a need for continuous movement throughout the day.

A study found a decline in bariatric surgeries amid a rise in anti-obesity drug use among privately insured adults, with calls for improved obesity treatment access.

An MIT study found that for-profit hospice care reduces Medicare costs by about $29,000 per ADRD patient over five years, raising questions about current Medicare policies.